Sard Verbinnen & Co. represents Montreal’s Atrium Innovations as the “science-based” natural supplements company agrees to be acquired by Nestle for $2.3B cash/debt.
Artrium markets products in more than 50 countries under brands such as Garden of Life, Douglas Laboratories, Genestra Brands and Pure Encapsulations.
CEO Peter Luther said Atrium shares Nestle Health Science group’s philosophy of “helping people lead healthier lives by providing good-for-you products that are made with the highest standards for quality and efficacy.”
Permira Funds, which has invested in more than 30 consumer companies such as Dr. Martens, Hugo Boss, John Masters Organics and Akindo Sushiro sushi restaurant company, controls Atrium.
SV&C’s Brooke Gordon, Devin Broda and Julie Rudnick handle the deal that is expected to close during the first-quarter of 2018.